$372.33−0.03%Close 17 Nov 2026 · Market value $30.00B
In its results release of 28 Oct 2026 (Q3 FY2026), Labcorp gave 3 forecasts in figures, among them revenue growth of +5.9% to +6.7% for FY2026. Over the last two years, results landed above the company's own last range 0 of 3 times, within it 3 and below it 0.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 28 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| Revenue growth | FY2026 | +5.9% to +6.7% | Revenue growth range of 5.9% to 6.7%; up 50 basis points at the midpoint |
|---|
| EPS · Adjusted | FY2026 | $18.30 to $18.70 | Adjusted EPS range of $18.30 to $18.70; up 18 cents at the midpoint |
|---|
| Free cash flow | FY2026 | $1.24B to $1.36B | Free Cash Flow $1,240 - $1,360 |
|---|
Source: the company's earnings release.
Guidance against results above 0 · within 3 · below 0
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Revenue | FY2026 | $14.61B to $14.79B | Given once | — | To come |
|---|
| Revenue growth | FY2026 | +5.9% to +6.7% | Raised twice | — | To come |
|---|
| EPS · Adjusted | FY2026 | $18.30 to $18.70 | Raised twice | — | To come |
|---|
| Free cash flow | FY2026 | $1.24B to $1.36B | Unchanged | — | To come |
|---|
| Tax rate · Adjusted | FY2026 | About 23% | Given once | — | To come |
|---|
| Revenue | FY2025 | $13.88B to $14.05B | Given once | $13.95B | Within the range |
|---|
| EPS · Adjusted | FY2025 | $16.15 to $16.50 | Raised once | $16.44 | Within the range |
|---|
| EPS · Adjusted | FY2024 | $14.30 to $14.70 | Given once | $14.57 | Within the range |
|---|
LH in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.